Gilead’s Twice-Yearly HIV Prevention Shot Beats Coverage Goals

By Luke Zarzecki / November 3, 2025 at 4:59 PM

Gilead’s twice yearly HIV prevention shot has achieved 75% U.S. payor coverage, beating the company’s goal by three months, the company revealed in an earnings call on Oct. 30.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.